{"disease":{"id":"ccr5-tropic-drug-resistant-hiv-infection","name":"CCR5 Tropic Drug Resistant HIV Infection","therapeutic_area":"","data":{},"enrichment_level":0,"last_enriched_at":null,"visit_count":0,"created_at":"2026-04-19T18:31:21.150Z","updated_at":"2026-04-19T18:39:44.960Z","meddra_pt":null,"meddra_code":null,"icd10_codes":null,"synonyms":[],"prevalence_global":null,"prevalence_us":null,"marketed_drug_count":2,"pipeline_drug_count":0,"trial_count":0},"drugs":{"marketed":[{"drug_id":"maraviroc","indication_name":"CCR5 Tropic Drug Resistant HIV Infection","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Selzentry","generic_name":"MARAVIROC","company_name":"GSK","drug_phase":"marketed","molecular_target":"C-C chemokine receptor type 5","drug_class":"CCR5 Co-receptor Antagonist [EPC]","quality_score":75,"revenue":null,"mechanism":"Selzentry works by blocking the CCR5 receptor on immune cells, preventing HIV from entering and infecting these cells."},{"drug_id":"selzentry","indication_name":"CCR5 Tropic Drug Resistant HIV Infection","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Selzentry","company_name":"Icahn School of Medicine at Mount Sinai","drug_phase":"marketed","molecular_target":"Multidrug and toxin extrusion protein 1, C-C chemokine receptor type 5, C-C chemokine receptor type 5","drug_class":"","quality_score":null,"revenue":null,"mechanism":null}],"pipeline":[],"offLabel":[],"totalMarketed":2,"totalPipeline":0},"trials":{"data":[],"total":0},"guidelines":[],"source":"Drug Landscape verified database"}